UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 20, 2021 4:00 P.M.

Form:	S-3
CIK: 0001661460 Company Name: Poseida Therapeutics, Inc. File Number: 333-258804